bullish
Taisho Pharma Seems the Best Suitor for Takeda’s Japan OTC Business
400 Views24 Jun 2020 13:40
It was reported by several news media outlets that Blackstone, Bain Capital, CVC Capital Partners and Taisho Pharmaceutical are among the final...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 6-minute read)
Discussions
(Paid Plans Only)
- Shin-Etsu: All Segments Seeing Declines; Earnings Rebound Could Take Longer31 Jul 2020
- Hoya 1Q Results: Another Quarter Impacted by the Pandemic but Recovery Is Ahead29 Jul 2020
- Olympus Finally Sells Its Loss-Making Camera Business25 Jun 2020
- Taisho Pharma Seems the Best Suitor for Takeda’s Japan OTC Business24 Jun 2020
- Hygeia Healthcare IPO (Part I): A Better Healthcare16 Jun 2020
- Takeda Offloads Asia-Focused Drugs to South Korea’s Celltrion12 Jun 2020
- Takeda Pharma Divests Yet Another Non-Core Asset to Pay-Off Debt and Focus on Core Areas29 Apr 2020
x